RIMI - Repository of the Institute for Medical Research
Institute for Medical Research
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   RIMI
  • Institut za medicinska istraživanja
  • Radovi istraživača / Researchers' publications
  • View Item
  •   RIMI
  • Institut za medicinska istraživanja
  • Radovi istraživača / Researchers' publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings

Thumbnail
2019
948.pdf (412.6Kb)
Authors
Bobić, Branko
Villena, Isabelle
Stillwaggon, E.
Article (Published version)
Metadata
Show full item record
Abstract
Congenital toxoplasmosis (CT), the result of a primary infection of pregnant women with Toxoplasma gondii which was transmitted to the fetus, may result in mild to deep injuries occurring in the newborn or later in its development or in adolescence. The visual and cognitive impairment that can result imposes substantial economic costs on the individual and society. Numerous observational studies favor the conclusion that, with preventive measures currently available, it is possible to reduce the incidence of infections in pregnant women, the incidence of fetal infection by preventing transplacental transmission, and the gravity of injury in infected newborns. Treatment of infected newborns can also reduce the severity of consequences and the frequency of their occurrence later in life. Prevention programs, however, are applied in only a few countries; in most countries implementation of a national prevention program has not been considered or has been thought to be too expensive. This ...article lists the methods of prevention of CT and describes existing national prevention programs in France and Austria. It analyzes the economic costs and benefits of maternal screening for CT prevention and mitigation for society and for health systems. The economic feasibility of implementing national screening in low-prevalence, high-cost countries is illustrated with the example of the United States. New diagnostic tools are discussed and the implication of lower costs is considered, for countries with well-established screening programs as well as those with inadequate prenatal care networks.

Keywords:
Congenital toxoplasmosis / Economic benefits / Economic costs / Prevention / Screening
Source:
Food & Waterborne Parasitology, 2019, 16
Funding / projects:
  • Control of infections by Apicomplexan pathogens: from novel drug targets to prediction (RS-41019)

DOI: 10.1016/j.fawpar.2019.e00058

ISSN: 2405-6766

Scopus: 2-s2.0-85064851464
[ Google Scholar ]
14
URI
http://rimi.imi.bg.ac.rs/handle/123456789/951
Collections
  • Radovi istraživača / Researchers' publications
Institution/Community
Institut za medicinska istraživanja
TY  - JOUR
AU  - Bobić, Branko
AU  - Villena, Isabelle
AU  - Stillwaggon, E.
PY  - 2019
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/951
AB  - Congenital toxoplasmosis (CT), the result of a primary infection of pregnant women with Toxoplasma gondii which was transmitted to the fetus, may result in mild to deep injuries occurring in the newborn or later in its development or in adolescence. The visual and cognitive impairment that can result imposes substantial economic costs on the individual and society. Numerous observational studies favor the conclusion that, with preventive measures currently available, it is possible to reduce the incidence of infections in pregnant women, the incidence of fetal infection by preventing transplacental transmission, and the gravity of injury in infected newborns. Treatment of infected newborns can also reduce the severity of consequences and the frequency of their occurrence later in life. Prevention programs, however, are applied in only a few countries; in most countries implementation of a national prevention program has not been considered or has been thought to be too expensive. This article lists the methods of prevention of CT and describes existing national prevention programs in France and Austria. It analyzes the economic costs and benefits of maternal screening for CT prevention and mitigation for society and for health systems. The economic feasibility of implementing national screening in low-prevalence, high-cost countries is illustrated with the example of the United States. New diagnostic tools are discussed and the implication of lower costs is considered, for countries with well-established screening programs as well as those with inadequate prenatal care networks.
T2  - Food & Waterborne Parasitology
T1  - Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings
VL  - 16
DO  - 10.1016/j.fawpar.2019.e00058
UR  - conv_5071
ER  - 
@article{
author = "Bobić, Branko and Villena, Isabelle and Stillwaggon, E.",
year = "2019",
abstract = "Congenital toxoplasmosis (CT), the result of a primary infection of pregnant women with Toxoplasma gondii which was transmitted to the fetus, may result in mild to deep injuries occurring in the newborn or later in its development or in adolescence. The visual and cognitive impairment that can result imposes substantial economic costs on the individual and society. Numerous observational studies favor the conclusion that, with preventive measures currently available, it is possible to reduce the incidence of infections in pregnant women, the incidence of fetal infection by preventing transplacental transmission, and the gravity of injury in infected newborns. Treatment of infected newborns can also reduce the severity of consequences and the frequency of their occurrence later in life. Prevention programs, however, are applied in only a few countries; in most countries implementation of a national prevention program has not been considered or has been thought to be too expensive. This article lists the methods of prevention of CT and describes existing national prevention programs in France and Austria. It analyzes the economic costs and benefits of maternal screening for CT prevention and mitigation for society and for health systems. The economic feasibility of implementing national screening in low-prevalence, high-cost countries is illustrated with the example of the United States. New diagnostic tools are discussed and the implication of lower costs is considered, for countries with well-established screening programs as well as those with inadequate prenatal care networks.",
journal = "Food & Waterborne Parasitology",
title = "Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings",
volume = "16",
doi = "10.1016/j.fawpar.2019.e00058",
url = "conv_5071"
}
Bobić, B., Villena, I.,& Stillwaggon, E.. (2019). Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings. in Food & Waterborne Parasitology, 16.
https://doi.org/10.1016/j.fawpar.2019.e00058
conv_5071
Bobić B, Villena I, Stillwaggon E. Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings. in Food & Waterborne Parasitology. 2019;16.
doi:10.1016/j.fawpar.2019.e00058
conv_5071 .
Bobić, Branko, Villena, Isabelle, Stillwaggon, E., "Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings" in Food & Waterborne Parasitology, 16 (2019),
https://doi.org/10.1016/j.fawpar.2019.e00058 .,
conv_5071 .

DSpace software copyright © 2002-2015  DuraSpace
About RIMI | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About RIMI | Send Feedback

OpenAIRERCUB